Business
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH&#...
About this update from Medicenna Therapeutics Corp.
[{"type":"text","content":"ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York CityConference to Feature Leading Healthcare Companies and Institutional Investors for 1x1/Small Group Meetings and Panels\n\n\n\n NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”),\n \n\n www.roth.com\n \n\n , is pleased to announce it will host the\n \n\n 4th Annual ROTH Healthcare Opportunities Conference\n \n\n on October 9, 2025, at the Metropolitan Club, New York City, NY.\n \n\n The Annual ROTH Healthcare Opportunities Conference will once again bring together C-suite executives from innovative public and private healthcare companies, alongside leading institutional investors and sector specialists exploring new opportunities. This year’s participating companies will span key subsectors including Biotechnology, Medical Technologies, Biopharmaceuticals, and Pharmaceuticals.\n \n\n This exclusive, invite-only event will feature 1x1/small group meetings between company executives and ROTH’s institutional clients. These 25-minute meetings offer a valuable opportunity for participants to engage in deep discussions about company roadmaps, explore synergies, understand investment strategies, and lay the groundwork for potential collaborations.\n \n\n The conference will commence with a Breakfast Panel titled \"Small Firms Tackling Blockbuster Indications\", moderated by\n \n Boobalan Pachaiyappan, Ph.D.\n \n , Managing Director, Sr. Research Analyst. During this session, participating companies (CRVO, NWRN.SW, RVPH) will share their drug development experience while highlighting industry, sector and indication-specific opportunities and challenges.\n \n\n In addition to the breakfast panel, attendees will have the opportunity to attend three additional\n \n Panel Discussions\n \n covering cutting-edge topics in healthcare innovation:\n \n\n\n Novel AML Therapies Showing Clear Clinical Progress (moderator:\n \n Jonathan Aschoff, Ph.D.\n \n ; participating companies: APVO, MBRX)\n \n\n Embracing New Uncertainty: A Round Table Discussion with an FDA Expert: Paul Kim J.D. (moderator:\n \n Boobalan Pachaiyappan, Ph.D.\n \n ; participating companies: CAPR, CING, PYPD)\n \n\n Breakthrough Technologies Spearheading the Next Wave of Innovation (moderator:\n \n Boobalan Pachaiyappan...